Rights and permissions
About this article
Cite this article
β-agonists do not increase MI risk in COPD patients. React. Wkly. 941, 4 (2003). https://doi.org/10.2165/00128415-200309410-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200309410-00008